MAPT and Alzheimer disease: Unlike the development of Aβ and tau pathology in transgenic mouse lines that occurs over the course of months, the pathological accumulation of Aβ and tau aggregates in the human brain occurs over the course of years prior to the onset of AD-related clinical symptoms [40].